Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Health and Healthcare

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

256 Articles

Jon C. Ogg | May 23, 2019 at 11:40 AM EDT

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and…

Chris Lange | May 21, 2019 at 9:05 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors…

Chris Lange | Apr 16, 2019 at 12:15 PM EDT

What CRISPR Has Planned for Transfusion-Dependent Beta Thalassemia

CRISPR Therapeutics shares jumped on Tuesday after the firm announced that the FDA has granted Fast Track Designation for its…

Jon C. Ogg | Mar 26, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex, Voya and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping…

Jon C. Ogg | Mar 19, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Boeing, Booking, Camping World, Domino’s, iRobot, MetLife, Neogen, Southern Copper, Vertex, Worldpay and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Boeing, Booking, Camping World, Domino's Pizza, iRobot, MetLife, Neogen,…

Chris Lange | Jan 7, 2019 at 8:35 AM EST

Major Biopharma Catalysts Coming in the First Quarter of 2019

Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

Jon C. Ogg | Jan 2, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma,…

Jon C. Ogg | Dec 19, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Biogen, FedEx, Intel, Micron, Roku, Shake Shack and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Baker Hughes, Biogen, FedEx, Intel, Micron Technology, Roku…

Lee Jackson | Nov 9, 2018 at 7:05 AM EST

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all…

Chris Lange | Oct 11, 2018 at 12:05 PM EDT

CRISPR Wins FDA Approval for Human Trials

CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration…

Lee Jackson | Sep 27, 2018 at 8:35 AM EDT

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term,…

Lee Jackson | Sep 21, 2018 at 8:45 AM EDT

Stifel Has Red-Hot Biotech Stocks to Buy With Huge Upside Potential

A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove…

Chris Lange | Aug 16, 2018 at 11:15 AM EDT

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

Vertex Pharmaceuticals shares saw a handy gain on Thursday after the FDA gave a nod to Vertex’s cystic fibrosis treatment.

Chris Lange | May 31, 2018 at 8:35 AM EDT

CRISPR Faces FDA Clinical Hold

CRISPR Therapeutics shares saw a significant drop on Thursday morning after an announcement that the FDA placed a clinical hold…

Lee Jackson | May 1, 2018 at 8:40 AM EDT

Red-Hot Biotech and Tech Companies Highlight Jefferies Top Stocks to Buy

While these four stocks are better suited for accounts that have a higher risk tolerance, they all make good sense…

1 … 4 5 6 7 8 … 18

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

What CRISPR Has Planned for Transfusion-Dependent Beta Thalassemia

Top Analyst Upgrades and Downgrades: Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex, Voya and More

Top Analyst Upgrades and Downgrades: Boeing, Booking, Camping World, Domino’s, iRobot, MetLife, Neogen, Southern Copper, Vertex, Worldpay and More

Major Biopharma Catalysts Coming in the First Quarter of 2019

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Biogen, FedEx, Intel, Micron, Roku, Shake Shack and More

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

CRISPR Wins FDA Approval for Human Trials

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Stifel Has Red-Hot Biotech Stocks to Buy With Huge Upside Potential

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

CRISPR Faces FDA Clinical Hold

Red-Hot Biotech and Tech Companies Highlight Jefferies Top Stocks to Buy

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here’s What a Plan Looks Like.

The Fidelity Bond ETF Quietly Outperforming Vanguard’s BND Over The Last Decade

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here’s What a Plan Looks Like.

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

What CRISPR Has Planned for Transfusion-Dependent Beta Thalassemia

Top Analyst Upgrades and Downgrades: Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex, Voya and More

Top Analyst Upgrades and Downgrades: Boeing, Booking, Camping World, Domino’s, iRobot, MetLife, Neogen, Southern Copper, Vertex, Worldpay and More

Major Biopharma Catalysts Coming in the First Quarter of 2019

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Biogen, FedEx, Intel, Micron, Roku, Shake Shack and More

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

CRISPR Wins FDA Approval for Human Trials

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Stifel Has Red-Hot Biotech Stocks to Buy With Huge Upside Potential

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

CRISPR Faces FDA Clinical Hold

Red-Hot Biotech and Tech Companies Highlight Jefferies Top Stocks to Buy

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here’s What a Plan Looks Like.

The Fidelity Bond ETF Quietly Outperforming Vanguard’s BND Over The Last Decade

Featured Reads

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.